Afyren SAS (ALAFY) - Total Liabilities
Based on the latest financial reports, Afyren SAS (ALAFY) has total liabilities worth €4.19 Million EUR (≈ $4.89 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check ALAFY financial resilience to evaluate the company's liquid asset resilience ratio.
Afyren SAS - Total Liabilities Trend (2018–2025)
This chart illustrates how Afyren SAS's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Afyren SAS asset portfolio.
Afyren SAS Competitors by Total Liabilities
The table below lists competitors of Afyren SAS ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Chainqui Construction Development Co Ltd
TW:2509
|
Taiwan | NT$10.34 Billion |
|
Dharmaj Crop Guard Limited
NSE:DHARMAJ
|
India | Rs5.12 Billion |
|
Aspen Group Ltd
TA:ASGR
|
Israel | ILA2.68 Billion |
|
Fine DNC Co. Ltd
KQ:049120
|
Korea | ₩53.07 Billion |
|
Oxford Square Capital Corp
NASDAQ:OXSQ
|
USA | $155.78 Million |
|
Gongin Precision Industrial Co Ltd
TWO:3178
|
Taiwan | NT$1.55 Billion |
|
Maxigen Biotech Inc
TW:1783
|
Taiwan | NT$534.02 Million |
|
Nicola Mining Inc
V:NIM
|
Canada | CA$17.60 Million |
Liability Composition Analysis (2018–2025)
This chart breaks down Afyren SAS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Afyren SAS's balance sheet to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 23.73 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 12.05 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.07 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.06 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Afyren SAS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Afyren SAS (2018–2025)
The table below shows the annual total liabilities of Afyren SAS from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €4.19 Million ≈ $4.89 Million |
-28.59% |
| 2024-12-31 | €5.86 Million ≈ $6.85 Million |
-32.06% |
| 2023-12-31 | €8.63 Million ≈ $10.09 Million |
-37.68% |
| 2022-12-31 | €13.84 Million ≈ $16.19 Million |
-9.47% |
| 2021-12-31 | €15.29 Million ≈ $17.88 Million |
-6.26% |
| 2020-12-31 | €16.32 Million ≈ $19.07 Million |
+56.18% |
| 2019-12-31 | €10.45 Million ≈ $12.21 Million |
-14.86% |
| 2018-12-31 | €12.27 Million ≈ $14.34 Million |
-- |
About Afyren SAS
AFYREN SAS provides biobased products to replace petroleum-based molecules in France. It offers acetic, propionic, butyric and isobutyric, valeric and isovaleric, and caproic acids. The company's products are used in the flavors and fragrances, lubricants and functional fluids, feed, food, life sciences, and materials science markets. The company was founded in 2012 and is headquartered in Clermo… Read more